blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0198474

EP0198474 - Hepatitis B surface antigen formed by recombinant DNA techniques, vaccines, diagnostics, cell lines and methods of forming same [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.05.1997
Database last updated on 12.10.2024
Most recent event   Tooltip02.05.1997No opposition filed within time limitpublished on 18.06.1997 [1997/25]
Applicant(s)For all designated states
SmithKline Beecham Biologicals S.A.
89 rue de l'Institut
1330 Rixensart / BE
[N/P]
Former [1996/32]For all designated states
SMITHKLINE BEECHAM BIOLOGICALS s.a.
89 rue de l'Institut
B-1330 Rixensart / BE
Former [1994/47]For all designated states
SmithKline Beecham Biologics SA
Rue de l'Institut 89
B-1330 Rixensart / BE
Former [1986/43]For all designated states
ENDOTRONICS INC.
8500 Evergreen Boulevard
Coon Rapids Minnesota 55433 / US
Inventor(s)01 / Salstrom, John S.
13050 Harriet Avenue No. 329
Burnsville Minnesota 55337 / US
02 / Rohrbaugh, Mark L.
1184 Mackubin Street No. 105
St. Paul Minnesota 55117 / US
03 / Thoma, Hans A.
Giselastrasse 3
D-8000 Munich 40 / DE
[1986/43]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [1986/43]VOSSIUS & PARTNER
Postfach 86 07 67
D-81634 München / DE
Application number, filing date86105183.715.04.1986
[1986/43]
Priority number, dateEP1985010452115.04.1985         Original published format: EP 85104521
[1986/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0198474
Date:22.10.1986
Language:EN
[1986/43]
Type: B1 Patent specification 
No.:EP0198474
Date:26.06.1996
Language:EN
[1996/26]
Search report(s)(Supplementary) European search report - dispatched on:EP02.09.1986
ClassificationIPC:C12N15/51, C12N5/10, C07K14/02, C12P21/02, A61K39/29
[1996/26]
CPC:
C07K14/005 (EP); C07K14/61 (EP); G01N33/5761 (EP);
G01N33/5764 (EP); A61K39/00 (EP,US); C12N2730/10122 (EP);
G01N2800/52 (EP) (-)
Former IPC [1986/43]C12N15/00, C12N5/00, C07K13/00, C12P21/02, G01N33/569, G01N33/576, A61K39/29
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1986/43]
TitleGerman:Mittels rekombinanter DNS-Techniken gebildetes Hepatitis-B-Oberflächenantigen, Impfstoffe, Diagnostika, Zellinien und Verfahren zu deren Herstellung[1986/43]
English:Hepatitis B surface antigen formed by recombinant DNA techniques, vaccines, diagnostics, cell lines and methods of forming same[1986/43]
French:Antigène de surface de l'hépatite B produit par des techniques d'ADN recombinant, vaccins, diagnostics, lignées cellulaires et leur procédé de préparation[1986/43]
Biological materialThis application mentions deposited biological material, check the file for details
MiscellaneousEPB 1996/26: Teilanmeldung 95119966.0 eingereicht am 18/12/95
EPB 1996/26: Divisional application 95119966.0 filed on 18/12/95
EPB 1996/26: Demande divisionnaire 95119966.0 déposée le 18/12/95
Examination procedure22.04.1987Examination requested  [1987/26]
09.09.1988Despatch of a communication from the examining division (Time limit: M08)
18.05.1989Reply to a communication from the examining division
08.02.1990Despatch of a communication from the examining division (Time limit: M06)
20.08.1990Reply to a communication from the examining division
23.05.1991Despatch of a communication from the examining division (Time limit: M06)
02.12.1991Reply to a communication from the examining division
26.06.1992Despatch of a communication from the examining division (Time limit: M06)
09.12.1992Reply to a communication from the examining division
25.06.1993Despatch of a communication from the examining division (Time limit: M07)
07.02.1994Reply to a communication from the examining division
27.06.1994Despatch of a communication from the examining division (Time limit: M06)
09.01.1995Reply to a communication from the examining division
23.01.1995Despatch of a communication from the examining division (Time limit: M02)
03.04.1995Reply to a communication from the examining division
06.06.1995Despatch of communication of intention to grant (Approval: No)
22.12.1995Despatch of communication of intention to grant (Approval: later approval)
29.12.1995Communication of intention to grant the patent
09.04.1996Fee for grant paid
09.04.1996Fee for publishing/printing paid
Divisional application(s)EP95119966.0  / EP0719863
Opposition(s)27.03.1997No opposition filed within time limit [1997/25]
Fees paidRenewal fee
29.04.1988Renewal fee patent year 03
26.04.1989Renewal fee patent year 04
26.04.1990Renewal fee patent year 05
29.04.1991Renewal fee patent year 06
29.04.1992Renewal fee patent year 07
29.04.1993Renewal fee patent year 08
29.04.1994Renewal fee patent year 09
28.04.1995Renewal fee patent year 10
25.03.1996Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XD]EP0013828  (BIOGEN NV [NL]);
 [X]WO8301783  (UNIVERSITY PATENTS INC [US]);
 [X]WO8402534  (US COMMERCE [US]);
 [XP]EP0155198  (INST NAT SANTE RECH MED [FR])
ExaminationEP0020251
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.